logging this because the persistent-mark question keeps coming up and most of the answers are either “you bruised, relax” or “infection, see a doctor,” and neither matched what i actually tracked. background: pre-diabetic, a1c was 6.1, on tirzepatide since last fall, currently 7.5mg subq. i rotate sites and log injection day + site, partly because i got tired of guessing which quadrant i’d hit last week. the thing i want to add: in march i got a mark lower-left abdomen that stuck around almost 7 weeks. not painful, not warm, no spreading edge, just a dull brownish-yellow that would not finish fading. my first instinct was the same one everybody jumps to: bad batch, contamination, something wrong with the compound. that was the wrong frame, and here’s why i think so. i’d pulled that same dose from the same vial for three other injections that left nothing. dose 1 and dose 4 out of one multi-dose vial aren’t identical chemistry as the headspace climbs, sure, but a localized mark that long after a single stick isn’t a degradation signal, it’s a mechanical one. what actually correlated in my log: that was a day i pinched deeper and lower than usual, closer to the fascia, and i’m pretty sure i nicked a small subcutaneous vessel. blood that pools deeper takes way longer to clear than a surface bruise because it’s hemoglobin breaking down over a wider, slower-draining bed. nothing to do with the peptide at all. so the thing i’d push on with the “infection vs angle” binary: those aren’t the only two buckets. a deep subq bleed is its own third category and it’s the most common one for a mark that’s stubborn but totally asymptomatic. infection gives you heat, tenderness, an edge that grows. mine did none of that, it just sat there being ugly. what changed it for me wasn’t a cream. it was tightening two variables: i stopped going as deep on the thinner lower-abdomen sites and moved more rotations to where i actually have a bit more subcutaneous cushion, and i started letting the vial come up from fridge temp before injecting instead of pinning it cold, which i think was making me tense the pinch. since then, basically nothing past a day or two. the reason i could even see the pattern is that i had site + day logged next to it. eyeballing it i’d have sworn the marks were random. the weekly trend summary in careclinic is what made the lower-left clustering obvious without me scrolling back through eight weeks of entries, which is the only reason i caught that it was a placement thing and not a compound thing. not medical advice, and if yours is warm, tender, or spreading that’s a genuinely different question than what i’m describing. but if it’s a flat painless mark that just won’t quit, log where and how deep you’re going before you blame the vial. mine read as a bad batch right up until the log said otherwise.
the three-bucket framing is more useful than the binary most threads are working w/, and the timeline maps right - pooled hemoglobin in deeper subq tissue clearing over 6-7 weeks is exactly what you’d expect from a small vessel nick near the fascia. one caveat worth adding: compounded tiz carries a small real risk of localized granuloma from excipient deposition, which can also present as a persistent flat painless discoloration w/ no heat or tenderness. the distinguishing feature is texture - granuloma tends to have a palpable firmness or nodularity that a resolved bleed doesn’t. purely surface color with no texture change, ur mechanical read is almost certainly right.
the texture distinction is the right one to reach for first, palpable nodularity vs flat color does separate an organized granuloma from a resolved bleed, so credit there. where i’d push is “compounded tiz carries a small real risk of localized granuloma from excipient deposition.” that’s doing more work than the framing supports two ways. one, an injection-site granuloma isn’t a compounding signal the way that sentence reads. foreign-body granulomas form around injected material regardless of source, the trigger is the deposit and the local immune response to it, not whether the vial came from a 503a vs a branded pen. attributing it to excipient deposition specifically points the finger at compound integrity when the more parsimonious read is just subcutaneous foreign-body response, which you can get off any injectable. that’s the same conflation i keep flagging on the integrity threads, framework-level “compounded is riskier” vs an actual finished-product mechanism. two, the timeline cuts against granuloma for my case anyway. a true organizing granuloma doesn’t resolve cleanly in 7 weeks and then stop recurring once i changed depth and let the vial warm up, it tends to persist longer and it’s tied to the deposit, not to my pinch angle. mine tracked to placement, which is a mechanical tell, not an immune one. the honest caveat back at you: a resolving deep hematoma isn’t texture-free in the acute window either. an organizing bleed can feel firm for the first couple weeks before it softens, so “purely surface color with no texture change” only cleanly rules in the mechanical read once you’re past that organizing phase. early on, firmness alone won’t sort bleed from granuloma. by the back half of the timeline, yeah, flat-and-fading with no nodule is the mechanical picture. worth keeping the granuloma bucket on the list, i just wouldn’t hang it on the compound. if anything it’s an argument for logging texture alongside color and depth, which i wasn’t doing until this mark.
The texture-plus-timeline combination you’re describing now is the better diagnostic frame than either one alone, and “logging texture alongside color and depth” is where this thread should have started. The granuloma-from-excipient framing does get deployed against compounded tiz specifically in a way it wouldn’t get deployed against, say, branded Mounjaro if someone reported the same nodule, and that asymmetry is worth naming. Foreign-body response to any injectable lipid excipient is plausible regardless of 503a vs 503b origin, so the attribution carries implicit framing even when it’s stated as a caveat. One thing your timeline argument doesn’t fully close: 7 weeks is actually within range for some small, self-resolving granulomas, not just for organized hematomas. The discriminating variable is what you already added - did depth-and-temperature correction stop recurrence? Recurrence-stopping is the mechanical tell. A granuloma at a deposit site doesn’t care that you changed your pinch angle, so if the pattern stopped tracking once you adjusted mechanics, that’s the stronger evidence than the timeline alone.